James Loerop

Jim Loerop has served as Aclaris’ Chief Business Officer since January 2022.

Prior to joining Aclaris, Jim served as Executive Vice President, Business Development and Strategic Planning at Anika Therapeutics, Inc., a publicly held global joint preservation company, where he was responsible for global business development activities. He also previously served as Chief Corporate Development Officer for Lupin Pharmaceuticals, Inc., where he was a member of the company’s Executive Leadership Team and was responsible for global business development and corporate development activities. Prior to joining Lupin, he held senior leadership roles at various companies in the pharmaceutical and life sciences industry, including at Alexion Pharmaceuticals, Inc. as Senior Vice President of Global Business Development, GlaxoSmithKline as Vice President of North America Business Development, and Stiefel Laboratories, Inc. as Senior Vice President of Global Corporate Development, prior to GSK’s acquisition of Stiefel.

Jim received his Bachelor of Science degree in marketing from Western Michigan University.